Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders

Background. The offspring of pregnant women with gestational diabetes mellitus (GDM) are vulnerable to be glucometabolic disorders. However, to date, few current studies focused on the associations of maternal accumulated glucose exposure before delivery with neonatal glucometabolic disorders and la...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengxia Mao, Ruilin Wu, Huan Yu, Yujiao Zhang, Wenbin Dong, Lile Zou, Xiaoping Lei
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2022/2478250
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561666691170304
author Zhengxia Mao
Ruilin Wu
Huan Yu
Yujiao Zhang
Wenbin Dong
Lile Zou
Xiaoping Lei
author_facet Zhengxia Mao
Ruilin Wu
Huan Yu
Yujiao Zhang
Wenbin Dong
Lile Zou
Xiaoping Lei
author_sort Zhengxia Mao
collection DOAJ
description Background. The offspring of pregnant women with gestational diabetes mellitus (GDM) are vulnerable to be glucometabolic disorders. However, to date, few current studies focused on the associations of maternal accumulated glucose exposure before delivery with neonatal glucometabolic disorders and large for gestational age (LGA) infants. This study is aimed at exploring the associations of maternal fructosamine (FMN) before delivery in GDM pregnant women with neonatal glucometabolic disorders in the first 3 days of life and LGA infants. Methods. The study subjects were the GDM pregnant women, who gave birth in our hospital from September 1, 2018 to January 31, 2021, and their newborns. The maternal FMN adjusted by serum albumin (FMNALB) before delivery was selected as exposure factors. A multivariate logistical regression model was used to calculate the odds ratios (OR) for neonatal glucometabolic disorders, hypoglycemia needing intervention (<2.6 mmol/L), and glucose intolerance (>7.0 mmol/L) in the first 3 days and LGA infants. Results. In GDM pregnant women, the newborns in the maternal FMNALB≥75th percentile (≥5.89 mmol/g) group had higher risks in neonatal glucometabolic disorders (aOR 2.50, 95% CI 1.34-4.65, P=0.004) and hypoglycemia (aOR 2.18, 95% CI 1.16-4.10, P=0.016). However, FMNALB≥75th percentile seemed to be not predictive of the glucose intolerance (aOR 1.76, 95% CI 0.82-3.79, P=0.149) and LGA (aOR 1.56, 95% CI 0.81-3.02, P=0.185). Further, in the sensitivity analysis, the newborns in the maternal FMNALB≥90th percentile (≥6.40 mmol/g) group also had higher risks in neonatal glucometabolic disorders (aOR 5.70, 95% CI 2.18-14.89, P<0.001) and hypoglycemia (aOR 3.72, 95% CI 1.48-9.31, P=0.005). Conclusions. The maternal FMNALB before delivery in GDM pregnant women was a useful biomarker to identify the offspring with high risk of neonatal glucometabolic disorders. However, the association between maternal FMNALB and the risk of LGA infants was not so strong.
format Article
id doaj-art-d30ed3ad68204e9fbf6b4671d1c1c687
institution Kabale University
issn 2314-6753
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d30ed3ad68204e9fbf6b4671d1c1c6872025-02-03T01:24:36ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/2478250Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic DisordersZhengxia Mao0Ruilin Wu1Huan Yu2Yujiao Zhang3Wenbin Dong4Lile Zou5Xiaoping Lei6Division of NeonatologyDivision of NeonatologyDivision of NeonatologyDepartment of PerinatologyDivision of NeonatologyDepartment of Histology and EmbryologyDivision of NeonatologyBackground. The offspring of pregnant women with gestational diabetes mellitus (GDM) are vulnerable to be glucometabolic disorders. However, to date, few current studies focused on the associations of maternal accumulated glucose exposure before delivery with neonatal glucometabolic disorders and large for gestational age (LGA) infants. This study is aimed at exploring the associations of maternal fructosamine (FMN) before delivery in GDM pregnant women with neonatal glucometabolic disorders in the first 3 days of life and LGA infants. Methods. The study subjects were the GDM pregnant women, who gave birth in our hospital from September 1, 2018 to January 31, 2021, and their newborns. The maternal FMN adjusted by serum albumin (FMNALB) before delivery was selected as exposure factors. A multivariate logistical regression model was used to calculate the odds ratios (OR) for neonatal glucometabolic disorders, hypoglycemia needing intervention (<2.6 mmol/L), and glucose intolerance (>7.0 mmol/L) in the first 3 days and LGA infants. Results. In GDM pregnant women, the newborns in the maternal FMNALB≥75th percentile (≥5.89 mmol/g) group had higher risks in neonatal glucometabolic disorders (aOR 2.50, 95% CI 1.34-4.65, P=0.004) and hypoglycemia (aOR 2.18, 95% CI 1.16-4.10, P=0.016). However, FMNALB≥75th percentile seemed to be not predictive of the glucose intolerance (aOR 1.76, 95% CI 0.82-3.79, P=0.149) and LGA (aOR 1.56, 95% CI 0.81-3.02, P=0.185). Further, in the sensitivity analysis, the newborns in the maternal FMNALB≥90th percentile (≥6.40 mmol/g) group also had higher risks in neonatal glucometabolic disorders (aOR 5.70, 95% CI 2.18-14.89, P<0.001) and hypoglycemia (aOR 3.72, 95% CI 1.48-9.31, P=0.005). Conclusions. The maternal FMNALB before delivery in GDM pregnant women was a useful biomarker to identify the offspring with high risk of neonatal glucometabolic disorders. However, the association between maternal FMNALB and the risk of LGA infants was not so strong.http://dx.doi.org/10.1155/2022/2478250
spellingShingle Zhengxia Mao
Ruilin Wu
Huan Yu
Yujiao Zhang
Wenbin Dong
Lile Zou
Xiaoping Lei
Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
Journal of Diabetes Research
title Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
title_full Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
title_fullStr Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
title_full_unstemmed Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
title_short Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
title_sort associations of maternal fructosamine before delivery in gestational diabetes mellitus pregnancies with neonatal glucometabolic disorders
url http://dx.doi.org/10.1155/2022/2478250
work_keys_str_mv AT zhengxiamao associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT ruilinwu associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT huanyu associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT yujiaozhang associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT wenbindong associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT lilezou associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders
AT xiaopinglei associationsofmaternalfructosaminebeforedeliveryingestationaldiabetesmellituspregnancieswithneonatalglucometabolicdisorders